AGP Executive Report
Last update: 2 hours agoHemp THC Crackdown: A Texas Supreme Court ruling lets the state treat some hemp-derived THC products as illegal Schedule I drugs, raising confusion for retailers and consumers over what’s actually sellable. Federal Policy Shock: A federal “intoxicating hemp” ban is reshaping risk and coverage, with a new “total THC” standard and a 0.4 mg per container cap expected to knock out most existing delta-8/HHC-style products. Medical Cannabis Access: Alabama opened a new medical dispensary in Talladega, expanding treatment options for qualifying patients. Regulatory Enforcement Abroad: Thailand revoked 35 Phuket cannabis shop permits and suspended 112 in an enforcement push, with legal action tied to cannabis and food rules. Industry Moves (ASX): Avecho’s cannabidiol insomnia trial cleared a key interim review and restarted final-stage recruitment; Neurotech is pushing a low-THC cannabis formulation through pharma-style pathways; Emyria keeps expanding its Empax clinic network. Retail/Branding: Minnesota’s Pot Mama’s is positioning dispensaries as welcoming, low-pressure spaces as the market grows.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
